Theravance Biopharma
TBPH
TBPH
96 hedge funds and large institutions have $1.22B invested in Theravance Biopharma in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $1.55B → $1.22B (-$328M)
Holders
96
Holding in Top 10
1
Calls
$245K
Puts
–
Top Buyers
| 1 | +$15.9M | |
| 2 | +$13M | |
| 3 | +$7.88M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.26M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.24M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$9.29M | |
| 3 | -$5.5M | |
| 4 |
Millennium Management
New York
|
-$4.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.59M |